Flash radiotherapy could replace conventional cancer treatments. It delivers radiation ultra-fast, reducing treatment ...

SAN FRANCISCO -- Older patients' survival in metastatic pancreatic cancer had a significant association with baseline ...

SAN FRANCISCO -- In an era dominated by pricey, high-tech drugs, the humble aspirin had a practice-changing impact on ...

In last year's update, AbbVie raised the combined 2027 net sales guidance for Skyrizi and Rinvoq by $6 billion to $27 billion ...

PCB Chairman Mohsin Naqvi emphasised prioritising Saim Ayub's long-term career over risking his fitness for the Champions ...

About the program: Project Equity is a 2021 initiative launched by the FDA's Oncology Center of Excellence to ensure that ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

Hematology-Oncology Associates of CNY has appointed Jennifer Pichoske as chief executive officer effective February 15, 2025.

Dr. Susumu Hijioka spoke about the benefit of this combination therapy in patients with unresectable or recurrent GEP-NETs, ...

An editor in his early 40s thought the tiny numb spot on his nose was innocuous. A year and six doctors later, he learned it ...

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

Bispecific antibodies have altered the multiple myeloma (MM) treatment landscape, but some practices still lack enough familiarity with these therapeutics to deliver them in outpatient settings.